Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0860 |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0867 |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0874 |
| Koselugoselumetinib | Selumetinib 10 mg/1 | CapsuleOral | AstraZeneca Pharmaceuticals LP | 0310-0610 |
| Koselugoselumetinib | Selumetinib 25 mg/1 | CapsuleOral | AstraZeneca Pharmaceuticals LP | 0310-0625 |
| Koselugoselumetinib | Selumetinib 5 mg/1 | GranuleOral | AstraZeneca Pharmaceuticals LP | 0310-0635 |
| Koselugoselumetinib | Selumetinib 7.5 mg/1 | GranuleOral | AstraZeneca Pharmaceuticals LP | 0310-0640 |
| Lapatinib | Lapatinib ditosylate 250 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-3237 |
| Lapatinib | Lapatinib ditosylate 250 mg/1 | Tablet, Film coatedOral | AvKARE | 42291-035 |
| Lapatinib | Lapatinib ditosylate 250 mg/1 | TabletOral | Lupin Pharmaceuticals, Inc. | 68180-801 |
| Lazcluzelazertinib | Lazertinib 80 mg/1 | Tablet, Film coatedOral | Janssen Biotech, Inc. | 57894-080 |
| Lazcluzelazertinib | Lazertinib 240 mg/1 | Tablet, Film coatedOral | Janssen Biotech, Inc. | 57894-240 |
| Lenvimalenvatinib | Lenvatinib 4 mg/1 | CapsuleOral | Eisai Inc. | 62856-704 |
| Lenvimalenvatinib | Lenvatinib 4 mg/1 | CapsuleOral | Eisai Inc. | 62856-708 |
| Lenvimalenvatinib | Lenvatinib 10 mg/1 | CapsuleOral | Eisai Inc. | 62856-710 |
| Lenvimalenvatinib | Lenvatinib 4 mg/1 | CapsuleOral | Eisai Inc. | 62856-712 |
| Lenvimalenvatinib | Lenvatinib 10 mg/1 | CapsuleOral | Eisai Inc. | 62856-720 |
| Leqselvideuruxolitinib phosphate | Deuruxolitinib phosphate 8 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 47335-108 |
| Litfuloritlecitinib | Ritlecitinib tosylate 50 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-0334 |
| Litfuloritlecitinib | Ritlecitinib tosylate 50 mg/1 | CapsuleOral | U.S. Pharmaceuticals | 63539-334 |
| Livtencitymaribavir | Maribavir 200 mg/1 | Tablet, CoatedOral | Takeda Pharmaceuticals America, Inc. | 64764-800 |
| Lorbrenalorlatinib | Lorlatinib 25 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0227 |
| Lorbrenalorlatinib | Lorlatinib 100 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-0231 |
| Lorbrenalorlatinib | Lorlatinib 25 mg/1 | Tablet, Film coatedOral | U.S. Pharmaceuticals | 63539-927 |
| Lytgobifutibatinib | Futibatinib 4 mg/1 | TabletOral | TAIHO PHARMACEUTICAL CO., LTD. | 64842-0120 |